Click a link below to view the mailing archive as if it had been sent to you.
| 2017-10-31 12:15 | | [forum discussion] Is Pfizer going to acquire Celgene? and more... |
| 2017-10-31 00:15 | | Insys founder resigns from board after charges in U.S. opioid bribe case and more... |
| 2017-10-30 12:15 | | Doctors who receive gifts from industry prescribe more branded drugs: study and more... |
| 2017-10-29 12:15 | | 3 Bright Spots in Merck's Q3 Results and more... |
| 2017-10-29 00:15 | | Freshly IPO’d Tocagen tweaks brain cancer gene therapy test and more... |
| 2017-10-28 12:15 | | Earnings Preview: What To Expect From Pfizer On Tuesday and more... |
| 2017-10-28 00:15 | | Amazon Said to Have Obtained Wholesale Pharmacy Licenses In at Least 12 States and more... |
| 2017-10-27 12:15 | | In a switch, Merck CEO signals he’s in a deal-making frame of mind and more... |
| 2017-10-27 00:15 | | Billionaire Insys founder charged in US opioid bribe case and more... |
| 2017-10-26 12:15 | | Bristol-Myers misses 3Q profit forecasts and more... |
| 2017-10-26 00:15 | | Why haven't biosimilars gained ground in the U.S.? and more... |
| 2017-10-25 12:15 | | Medtech industry mobilizes to repeal med device tax before suspension ends and more... |
| 2017-10-25 00:15 | | The Worrisome 'Why' Behind Eli Lilly's Change of Heart and more... |
| 2017-10-24 12:15 | | Eli Lilly Considering IPO or Sale of Its Elanco Animal Health Business and more... |
| 2017-10-24 00:15 | | Eyeing an IPO, ADC Therapeutics fuels pivotal cancer trials with a $200M mega-round backed by AstraZeneca and more... |
| 2017-10-23 12:15 | | Good quarter for Roche, but competition by biosimilars concerns investors and more... |
| 2017-10-22 12:15 | | 5 Key Drugs Critical to Johnson & Johnson's Future and more... |
| 2017-10-22 00:15 | | What's next for biopharma Q3 earnings and more... |
| 2017-10-21 12:15 | | GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine and more... |
| 2017-10-20 12:15 | | Merck plans to lay off 1,800 sales staffers in U.S. commercial shakeup and more... |
| 2017-10-20 00:15 | | Celgene just lost a crucial drug for its revenue stream after a clinical trial blowup and more... |
| 2017-10-19 12:15 | | [forum discussion] Merck reps discuss conference call - possible layoffs? and more... |
| 2017-10-18 12:15 | | Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer and more... |
| 2017-10-18 00:15 | | Johnson & Johnson says Puerto Rico plants 'fared well' in Maria, but 'intermittent' shortages possible and more... |
| 2017-10-17 12:15 | | New cancer drugs help J&J top profit estimates and more... |
| 2017-10-17 00:15 | | Court Finds Restasis Patents Invalid, Raises Concerns About Allergan, Mohawk Tribe Agreement and more... |
| 2017-10-16 12:15 | | Johnson & Johnson earnings: All eyes on hurricane impact and more... |
| 2017-10-16 00:15 | | That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it and more... |
| 2017-10-15 12:15 | | 'Double whammy' for Roche as manufacturing patent losses loom |
| 2017-10-14 12:15 | | We may soon have our first $1 million drug. Who will pay for it? And how? and more... |
| 2017-10-14 00:15 | | What Q3 earnings will look like for 5 pharma giants |
| 2017-10-13 12:15 | | Reckitt Benckiser is the most likely buyer of Pfizer’s Consumer Healthcare business and more... |
| 2017-10-13 00:15 | | Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote and more... |
| 2017-10-12 12:15 | | 5 Game-Changing Cancer Drug Innovations Being Developed Right Now and more... |
| 2017-10-12 00:15 | | Here’s how the diabetes industry’s leaders think about patient-centered R&D and more... |
| 2017-10-11 12:15 | | Ten big lobbying groups turn their guns on Allergan’s controversial patent gambit and more... |
| 2017-10-11 00:15 | | California enacts drug pricing transparency bill and more... |
| 2017-10-10 12:15 | | Allergan to pay $4 million to settle discrimination charges by former sales reps and more... |
| 2017-10-10 00:15 | | What's new on pharma's worry list? Cybersecurity, natural disasters, and much more and more... |
| 2017-10-09 12:15 | | Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September and more... |
| 2017-10-08 12:15 | | The FDA Is Approving Drugs at a Staggering Pace and more... |
| 2017-10-07 12:15 | | What keeps pharma execs up at night? Apparently a lot, says new report and more... |
| 2017-10-06 12:15 | | Lilly wards off another Alimta patent challenge, this time through IPR and more... |
| 2017-10-06 00:15 | | As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing and more... |
| 2017-10-05 12:15 | | U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent and more... |
| 2017-10-05 00:15 | | Cigna says it won’t cover OxyContin prescriptions through employer plans and more... |
| 2017-10-04 12:15 | | Supreme Court won’t review $3m pelvic mesh loss for J&J’s Ethicon and more... |
| 2017-10-03 12:15 | | Allergan defends Restasis deal by calling for review of patent challenge process and more... |
| 2017-10-03 00:15 | | Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for? and more... |
| 2017-10-02 12:15 | | Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B and more... |
| 2017-10-01 12:15 | | Merck Hepatitis C exit could lift the space’s two remaining drugmakers and more... |
